[Retracted] Comparison of Clinical Features and Inflammatory Markers between Kawasaki Disease Shock Syndrome and Kawasaki Disease without Shock: A Meta-Analysis

Table 1

Basic characteristics and quality evaluation results of the included literature.

Study	Gender (M/F)		Age		Sample sizes		Type of KD (CKD/IKD)		Fever duration (d)		NOS scores
	KDSS	KD without shock	KDSS	KD without shock	KDSS	KD without shock	KDSS	KD without shock	KDSS	KD without shock
Chen et al. [17]	11/10	13/11	4.9 ± 2.8 y	2.7 ± 1.9 y	21	24	16/5	16/8	6.7 ± 2.4	5.3 ± 0.6	7
Ma et al. [18]	17/10	19/24	43.41 ± 31.42 m	28.81 ± 21.51 m	27	43	8/19	2/41	10.63 ± 5.12	6.98 ± 2.45	6
Li et al. [19]	14/3	45/23	49.6∼90.0 m	14.2∼45.0 m	17	68	15/2	54/14	4∼5	NA	6
Qui et al. [20]	8/3	126/77	3∼120 m	2∼186 m	11	203	4/7	145/58	NA	NA	6
Gao et al. [16]	3/6	16/11	3.2 ± 3.3 y	2.0 ± 1.8	9	27	7/2	17/10	9.0 ± 3.1	7.1 ± 2.3	5
Gámez-González et al. [21]	6/7	53/38	0.5∼10.6 y	0.2∼8.4 y	13	91	6/5	61/27	8–23	3–29	6
Yang et al. [12]	4/9	104/70	2.2∼5.9 y	0.9∼3.9 y	13	174	NA	NA	NA	NA	7
Park et al. [22]	8/3	48/13	4.41 ± 3.62 y	3.17 ± 1.74 y	11	61	9/2	51/10	6.45 ± 2.27	6.39 ± 1.50	7
Shan et al. [23]	13/10	257/138	44 ± 23 m	22 ± 33 m	23	395	NA	NA	7.00 ± 2.00	6.00 ± 2.00	5

M： male; F： female; IKD: incomplete KD; CKD: complete KD; NA: not available; d: days; m: months; y: years; ①： age; ②: type of KD (CKD/IKD); ③: fever duration; ④: WBC count; ⑤: CRP; ⑥: ESR; ⑦: albumin; ⑧: alanine aminotransferase (ALT); ⑨: aspartate aminotransferase （AST）; ⑩ coronary artery disease.